MAPS MAPS
  • About
  • Research
  • News
  • Resources
  • Participate
  • Donate
  • Store

Observational Study of the Long-Term Efficacy of Ibogaine-Assisted Therapy (Mexico)

Category: Observational Studies of the Long-Term Efficacy of Ibogaine-Assisted Therapy

Principal Investigator: Thomas Brown, Ph.D.

This observational case study examined changes in substance use in individuals seeking ibogaine-based addiction treatment for opiate dependence at two independent ibogaine clinics in Mexico. This study was intended to gather information to evaluate whether ibogaine-assisted therapy helps opiate-dependent people to implement positive changes in their drug use patterns and in their lives. Twelve-month follow-up data was collected from participants in the study to examine whether ibogaine-assisted therapy facilitates improvements in quality of life that result in decreased harms associated with chronic or mismanaged opiate use. The study was fully approved and began enrollment on August 23, 2010. Results were published on May 25, 2017, in The American Journal of Drug and Alcohol Abuse

  • Published Paper: May 2017
  • Study Protocol: December 1, 2010
  • Subject Informed Consent Form: July 8, 2010
  • Results Presentation: October 2012

Donations are needed to support research into ibogaine as a treatment for substance abuse and dependence. MAPS will allocate 100% of any donation specifically restricted to this work upon request.

Filters

Stay Connected via Email

Subscribe for research updates, event announcements, news, multimedia, and more from the fast-growing fields of psychedelic and medical marijuana science, therapy, and spirituality.

Your email address:


Support Us

Donate Now

MAPS

We are a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Watch videos from Psychedelic Science 2017.

Media

  • March 21, 2021 Stanford Social Innovation Review: The Psychedelic Revolution in Mental Health
  • March 20, 2021 TED Radio Hour on NPR: Rick Doblin: How Can We Use Psychedelic-Assisted Therapy To Treat Trauma?
  • March 17, 2021 First Controlled Trial of Cannabis for the Treatment of PTSD Raises No Safety Concerns, Further Research is Needed to Determine Efficacy

About Us

  • Mission
  • Board of Directors
  • Staff
  • Financial Reports
  • MAPS Public Benefit Corporation (MAPS PBC)
  • 501(c)(3) & Bylaws
  • FAQ

Contact Us

3141 Stevens Creek Blvd #40563
San Jose, CA 95117
Phone: 831-429-MDMA (6362)
Fax: 831-429-6370
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Requests

Log in to your account


Privacy Policy | Donate

facebook twitter instagram
youtube linkedin
  • About
    • Mission
    • Board of Directors
    • Staff
    • Financial Reports
    • MAPS Public Benefit Corporation (MPBC)
    • 501(c)(3), EIN, and Bylaws
    • Privacy Policy
    • FAQ
  • Research
    • MDMA-Assisted Therapy
    • LSD-Assisted Psychotherapy
    • Ibogaine Therapy for Drug Addiction
    • Ayahuasca-Assisted Treatment
    • Medical Marijuana
    • Other Psychedelic Research
    • Research articles
  • News
    • MAPS Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • MAPS Podcast
    • Multimedia Library
    • Posts
    • MAPS Podcast
    • Emails
  • Resources
    • Brochures
    • Psychedelic Harm Reduction
    • Research Papers
    • Psychedelic Integration List
    • Psychedelic Bibliography
    • Free Books and Essays
    • Links
    • For Students
    • MAPS Forums on Bluelight
    • Psychedelic Science 2017 Videos
  • Participate
    • Global Psychedelic Dinners
    • Featured Events
    • Event Calendar
    • Volunteer
    • Global Psychedelic Dinners
    • Internships
    • MDMA Therapy Training Program
    • Careers
    • Participate in Research
  • Donate
    • Make a Gift
    • Why Give?
    • Funding Priorities
  • Store
    • Accessories
    • Apparel
    • Art
    • Books
    • Films
    • MAPS Bulletin: Back Issues